EU projects
The project "Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation - OSTEOproDENT", Project Code IP.1.1.03.0040, has currently launched.
Sartorius Croatia - Libra Elektronik d.o.o., in collaboration with its partners, the University of Zagreb - School of Medicine, Genera Research d.o.o., and the Dental Clinic Dario Bekavac, launched the implementation of the project "Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation - OSTEOproDENT" on January 13, 2025.
The project is being carried out under the rules of the Call for Proposals for Grant Allocation "Strengthening Strategic Partnerships for Innovation in the Process of Industrial Transition", within the Integrated Territorial Program.
The Managing Authority (MA) is the Ministry of Regional Development and EU Funds, while the Intermediate Body for Implementation of Operations (IBIO) is the Croatian Agency for SMEs, Innovations, and Investments.
Project Leader
Sartorius Croatia - Libra Elektronik d.o.o.
Partners
University of Zagreb, School of Medicine
Genera research d.o.o.
Dario Bekavac Dental Clinic
Total Project Value and EU Co-financing Amount
- Total project value: €4,674,018.25
- EU co-financing amount: €2,703,830.46
Project Implementation Period
January 13, 2025 – January 12, 2028
Project Manager and Contact Person: Ivica Granić
Email: ivica.granic@sartorius.hr
Phone: +385 1 3340 290
Project Summary
The project addresses the issue of inadequate bone tissue regeneration in dental medicine, a significant challenge in dental implant placement. The goal of the project is to develop an autologous substitute for dental bone grafts.
The project will be implemented within the SPIN consortium, contributing to the region's industrial transition towards an advanced healthcare industry, fostering innovation and competitiveness in Northern Croatia.
Project Description
This project aims to tackle the problem of limited bone tissue regeneration in dental medicine, which hinders successful dental implant placement. The primary objective is to develop an innovative autologous bone tissue substitute, enabling safer and more efficient alveolar ridge regeneration while reducing the need for complex surgical procedures.
The project includes the research and development of a minimally invasive therapy for alveolar ridge augmentation using a personalized formulation.
To ensure successful implementation, the SPIN consortium was established, bringing together experts from various fields to achieve the project’s research objectives.
The research will span 36 months and will be divided into two main phases:
- Phase I - Industrial Research (10 months)
- Phase II - Experimental Development (26 months)
This project will have a significant impact on the research community, dental medicine, and the industrial transition in Northern Croatia.
The results will be published in relevant scientific journals and presented at international conferences, increasing the visibility of Croatian research capacities in biomedicine and dental medicine.
Long-term Benefits
In the long run, the project will provide tangible benefits for dental professionals, patients, and researchers, reducing the need for invasive procedures and improving the outcomes of dental treatments.
Links:
The content of this website is the sole responsibility of Sartorius Croatia - Libra Elektronik d.o.o. The views and opinions expressed are those of the author only and do not necessarily reflect the official position of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them.
______________________________________________________________________________________________________________________________________________________________________________
Implementation of the project “Strengthening the International Competitiveness of SARTORIUS CROATIA-LIBRA ELEKTRONIK d.o.o.” is underway, project code: PK.1.3.10.0367
The company SARTORIUS CROATIA-LIBRA ELEKTRONIK d.o.o. began the implementation of the project on 1 November 2025, aimed at strengthening its international competitiveness through participation in four international trade fairs and the presentation of its own innovative solution, myScal. The project is implemented in accordance with the rules of the Call for Proposals for the award of grants entitled “Support to SMEs for Internationalisation”. The Intermediate Body Level 1 is the Ministry of Economy, while the Intermediate Body Level 2 is the Croatian Agency for SMEs, Innovations and Investments (HAMAG-BICRO).
Project beneficiary: SARTORIUS CROATIA-LIBRA ELEKTRONIK d.o.o.
Total project value: 86.850,00 EUR
EU grant: 58.299,00 EUR
Project implementation period: 01.11.2025. – 01.11.2026. (12 mjeseci)
Project manager and contact person: Ivica Granić (igranic@sartorius.hr, Tel: +385 91 201 6087)
Project summary
The project is focused on the internationalisation of business activities through participation in four international trade fairs and the presentation of the digital solution myScal, developed for the digitalisation and automation of calibration procedures for balances, weights and pipettes. The solution is intended for laboratories and organisations that perform measurements, calibrations and quality control. Its implementation enables more efficient, precise and reliable management of calibration processes. By participating in four international trade fairs, the applicant plans to present myScal to relevant customers, distributors, laboratories, research institutions and potential business partners. In addition to the product itself, the applicant will also present related consulting, implementation and user support services, thereby creating the prerequisites for long-term cooperation in targeted foreign markets.
Key activities
The main project activity includes the preparation for and participation in four international trade fairs relevant to laboratory technology, analytics, biotechnology, laboratory digitalisation and laboratories of the future.
Participation is planned at Analytica Munich, which will take place from 24 to 27 March 2026 in Germany. It is one of the world’s leading events for laboratory technology, analytics and biotechnology, bringing together manufacturers, researchers and experts from the laboratory sector.
The project also includes participation in London Lab Live, which will take place on 6 and 7 May 2026 in the United Kingdom. The fair brings together participants from the chemical, pharmaceutical, food, biotechnology, academic and other industries that use laboratory solutions and technologies.
The third planned fair is Future Labs Live, which will take place on 27 and 28 May 2026 in Switzerland. The event focuses on laboratories of the future, digitalisation, automation, robotics, artificial intelligence, data management and the sustainability of laboratory systems.
The fourth planned fair is Arab Lab, which will take place from 26 to 28 October 2026 in the United Arab Emirates. The fair brings together experts from the laboratory and analytical industries, chemistry, pharmaceuticals, biotechnology, clinical diagnostics, the food industry and environmental protection, with a particular focus on the markets of the Middle East and Africa.
The project also includes the preparation of promotional and presentation materials, communication with trade fair organisers, logistics coordination, presentation of products and services at the fairs, and follow-up processing of business contacts established during the events.
Expected results
Through the implementation of the project, the applicant will strengthen the international visibility of its digital solution myScal and increase opportunities for placing its products and services on foreign markets. Participation in international trade fairs will enable direct contact with potential customers, distributors, laboratories and strategic partners, as well as provide better insight into market needs, competition and trends in the field of laboratory digitalisation. The project is expected to contribute to increasing export potential, developing new sales channels, concluding new agreements with foreign partners and strengthening the long-term competitiveness of the applicant. The project is aligned with the Smart Specialisation Strategy of the Republic of Croatia until 2029, particularly in the area related to digital products and platforms, as well as the application of advanced laboratory and analytical solutions in fields connected to health, biotechnology and research.
More information:
The content of this website is the sole responsibility of SARTORIUS CROATIA-LIBRA ELEKTRONIK d.o.o.
Co-financed by the European Union under the Competitiveness and Cohesion Programme 2021–2027. The views and opinions expressed are solely those of the Beneficiary and do not necessarily reflect the official views of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them.
